MIRTAZAPINE

Generic: MIRTAZAPINE

Prasco LaboratoriesManufacturer
ORALRoute
MIRTAZAPINEActive Substance
2023-01-18Original Approval

MIRTAZAPINE is FDA application ANDA216751, sponsored by PRASCO. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
FATIGUE
4,001 reports
2
NAUSEA
3,967 reports
3
DRUG INEFFECTIVE
3,856 reports
4
TOXICITY TO VARIOUS AGENTS
3,802 reports
5
FALL
3,461 reports
6
OFF LABEL USE
3,442 reports
7
DIARRHOEA
3,394 reports
8
DRUG INTERACTION
3,117 reports
9
DIZZINESS
2,985 reports
10
DEATH
2,898 reports